| Financial Year |
March 31 2023 |
| Monetary Funds |
5,644,001,276.46 |
| Held-for-trading Financial Assets |
100,681,780.82 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
3,764,245.87 |
| Other Receivables |
294,840,014.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,383,636.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,714,351.24 |
| Total Current Assets |
6,056,385,304.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
151,270,296.25 |
| Investment Properties |
347,785,742.72 |
| Fixed Assetes |
932,069,877.96 |
| Under-construction Projects |
259,662,721.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,999,935,900.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
102,554,076.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
15,631,336,635.84 |
| Total Assets |
21,687,721,940.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
507,431,090.85 |
| Accounts Received In Advance |
37,512,121.87 |
| Employee Compensation Payable |
66,463,557.50 |
| Taxes Payable |
82,049,657.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,385,998.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
407,611,594.40 |
| Other Current Liabilities |
76,177,611.15 |
| Sub-Total of Current Liabilities |
1,241,631,631.78 |
| Long-term Loans |
6,244,343,018.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
77,559,700.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,209,315.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,461,732,149.22 |
| Total Liabilities |
7,703,363,781.00 |
| Paid-In Capital(Or Share Stock) |
1,658,610,000.00 |
| Capital Surplus |
412,269.32 |
| Surplus Reserve |
414,748,723.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,335,802,622.19 |
| Minority Stockholder's Interest |
1,598,958,224.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,385,399,934.85 |
| Owner's Equity（Stockholder's Equity） |
13,984,358,159.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,687,721,940.73 |
